Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$62,370
+$14,542 QoQ
Shares Held
52
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#4,518
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GILPIN WEALTH MANAGEMENT, LLC holds $2,297,589 across 11 Drug Manufacturers - General names. LLY ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,127 | $1,494,469 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,281 | $288,181 | |
| 3 | ABBV |
AbbVie Inc.
|
513 | $129,091 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,883 | $108,498 | |
| 5 | JNJ |
Johnson & Johnson
|
407 | $103,365 | |
| 6 | NVO |
Novo Nordisk A S
|
1,309 | $62,753 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
52 | $62,370 | |
| 8 | MRK |
Merck & Co., Inc.
|
276 | $35,466 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,370 | 52 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $47,828 | 52 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $53,734 | 50 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||